SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001172661-23-001301
Filing Date
2023-02-14
Accepted
2023-02-14 16:03:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 polar-smmt123122a2.htm SC 13G/A 86250
  Complete submission text file 0001172661-23-001301.txt   87917
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Subject) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88759 | Film No.: 23628612
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16 PALACE STREET LONDON X0 SW1E 5JD
Business Address 16 PALACE STREET LONDON X0 SW1E 5JD 02072272700
Polar Capital Holdings Plc (Filed by) CIK: 0001837309 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SC 13G/A